More literature review of what we know about the impact of cancer-affirming medicine for children and adults

Witness the lies. If you have institutional access to the full articles, please send to exulansicrelay@gmail.com

https://pubmed.ncbi.nlm.nih.gov/27084565/
This author claims that testosterone, a known carcinogen that induces mammary tumors in inbred rats, reduces breast cancer risk “with or without mastectomy.” I don’t believe this for a minute. The abstract itself says, “A major limitation in the study of testosterone therapy for transgender men is a paucity of high-quality data due to a shortage of randomised controlled trials (partly because of ethical issues), few prospective and long-term studies, the use of suboptimum control groups, loss to follow-up, and difficulties in recruitment of representative samples of transgender populations.” How are we concluding it magically reduces mammary tumors then, Michael S Irwig?

https://pubmed.ncbi.nlm.nih.gov/31261405/
There’s an enormous gaslight going on, as I documented in my “Night of Dialectical Ethnography on Twitter,” blaming the known carcinogenic effects of these drugs on transphobia. “Barriers to accessing appropriate and culturally competent care contribute to health disparities in transgender persons, such as increased rates of certain types of cancer, substance abuse, mental health conditions, infections, and chronic diseases”

https://pubmed.ncbi.nlm.nih.gov/32235278/
This study found a predictable carcinogenic effect of testosterone, and then concluded the sample size was too small to state the obvious and still pass peer review. The cowards couldn’t even conclude that carcinogens were contraindicated in cancer patients:
Summary: There is a relatively higher incidence of BCa in FtM on CSH therapy compared with cis men on TRT. Because of the small sample size of reported cases, we cannot delineate the exact relationship between testosterone therapy and BCa development. Additionally, we have limited data to suggest that TRT should or should not be contraindicated in cis men and FtM with a prior history of breast cancer.

https://pubmed.ncbi.nlm.nih.gov/33109526/
”Although it is usually rare, hormone-sensitive malignancies may arise, and long-term effects remain unknown” USUALLY RARE?! Is it sometimes common you bastards?
”Evidence relating to breast and reproductive tract cancers in the trans population is limited and insufficient to estimate cancer prevalence, and recommendations for screening and preventive care depend on the patients' hormonal and surgical status. Even less information exists regarding the sub-set of individuals with genetic predisposition for these malignancies.”

https://pubmed.ncbi.nlm.nih.gov/30693115/
Breast Cancer Development in a Transgender Male Receiving Testosterone Therapy
”While studies have shown increased risk of breast cancer in postmenopausal women with higher testosterone levels, data regarding premenopausal women is conflicting and little is known about breast cancer risk in transgender individuals receiving gender-affirming hormone therapy (GAHT),” The magical class of females who are presumed by science to be different from standard females because ??????? oh right we want to sell them a carcinogen.

https://pubmed.ncbi.nlm.nih.gov/30082887/
Yet another genius who magically figured out the difference between male and female brains then concluded there are no male and female brains: Sex differences and hormonal effects in presumed cisgender individuals have been well-studied and support the concept of a mosaic of both male and female "characteristics" in any given brain. Acknowledges lack of data for these experimental interventions: “While it is becoming increasingly common for transgender and gender non-binary individuals to block their transition to puberty and/or use gender-affirming hormone therapy (GAHT) to obtain their desired gender phenotype, little is known about the impact of these manipulations on brain structure and function.” This author is a proud member of Our Lady of the Perpetual Hormone Replacement Therapy and likely also Maculate Conception: “Research in this area has the potential to inform our understanding of the developmental origins of gender identity and sex difference in response to gonadal steroid manipulations.”

https://pubmed.ncbi.nlm.nih.gov/32939016/
”Testosterone therapy and breast histopathological features in transgender individuals” 2021

“The long-term effect of exogenous testosterone on breast tissues remains unclear” “TT for >12 months was associated with seven histopathological features.”
”Longer duration of TT was significantly associated with higher degrees of lobular atrophy.”
”The incidental findings of high-risk lesions and carcinoma as well as the risk of cancer in residual breast tissue after chest-contouring surgery warrant the consideration of culturally sensitive routine breast cancer screening protocols for transgender men and masculine-centered gender nonconforming individuals”. In other words they need chest cancer screenings. The authors acknowledge these interventions are being done for CULTURAL. REASONS.

https://pubmed.ncbi.nlm.nih.gov/28622261/
This study found that there is no increased risk of ovarian cancer in trans identifying females. Which is strange, because we know that androgen receptor activation generally promotes ovarian cancer growth. But these are special females so we throw the general rules out the window: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406955/ “ Specifically, androgen receptor activation appears to be associated with increased risks of developing ovarian cancer and inducing tumor progression”

https://pubmed.ncbi.nlm.nih.gov/16804313/
”Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient”
”The incidence of ovarian cancer among female-to-male transsexuals is not known. We report only the second case of ovarian cancer in a female-to-male transsexual while on androgen supplementation therapy”

Alright, I need to take a break for tonight before I get so mad I throw my apartment into the sun.